Alzheimer's disease & dementia

New memory drug moves into Phase 1 clinical study

An experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with support from the NIH Blueprint Neurotherapeutics Network, ...

Inflammatory disorders

Researchers find molecular trigger for brain inflammation

Brain inflammation is a key component of multiple sclerosis, Alzheimer's, Parkinson's, ALS, and most other major neurodegenerative diseases. How inflammation starts, how it's sustained, and how it contributes to these diseases ...

Medical research

Study identifies how zebrafish regrow their brains

(Medical Xpress)—An international team of scientists has discovered the mechanism by which zebrafish can re-grow brain neurons after they have suffered traumatic brain injury, and that this mechanism is associated with ...

page 9 from 40